Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrinolysis and atherosclerosis

A Hamsten1, P Eriksson

  • 1King Gustaf V Research Institute, Department of Medicine, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden.

Bailliere'S Clinical Haematology
|June 1, 1995
PubMed
Summary

Impaired fibrinolysis is increasingly linked to coronary heart disease (CHD). Further research into molecular mechanisms and genotype-specific factors is crucial for developing targeted prevention strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy.

Journal of internal medicine·2019
Same author

VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia.

International journal of laboratory hematology·2018
Same author

Integrative studies implicate matrix metalloproteinase-12 as a culprit gene for large-artery atherosclerotic stroke.

Journal of internal medicine·2017
Same author

Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases.

Lupus·2017
Same author

Exposure to depleted uranium during development affects neuronal differentiation in the hippocampal dentate gyrus and induces depressive-like behavior in offspring.

Neurotoxicology·2016
Same author

IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis.

Clinical and experimental immunology·2016

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Thrombosis Research

Background:

  • Growing evidence links impaired fibrinolytic function to coronary heart disease (CHD).
  • Epidemiological, clinical, and molecular studies have reinforced this association.
  • Established risk factors for atherosclerotic disease may influence fibrinolysis.

Purpose of the Study:

  • To elucidate the molecular mechanisms connecting risk factors, impaired fibrinolysis, and CHD.
  • To explore genotype-specific differences in susceptibility to metabolic disturbances affecting fibrinolysis.
  • To prioritize basic research on fibrinolysis in atherosclerosis and thrombotic complications.

Main Methods:

  • Review and synthesis of epidemiological, clinical, cell biological, and molecular biological studies.
  • Analysis of established risk factors for atherosclerotic disease.
  • Investigation into molecular mechanisms underlying fibrinolysis impairment.

Main Results:

  • The association between impaired fibrinolysis and CHD is strongly supported by recent research.
  • Understanding molecular mechanisms is key for developing targeted drugs.
  • The role of epiphenomena and genotype-specific variations requires further investigation.

Conclusions:

  • Modulating fibrinolytic function presents a promising avenue for CHD prevention.
  • Further research is needed to disentangle complex molecular pathways.
  • Prioritizing basic science research on fibrinolysis is essential for advancing cardiovascular health.

Related Experiment Videos